FAQs & How to use this site
Home | About Us | Contact Us
The Front Line
The Front Line: Charles D. Blanke, MD, SWOG Chair

PREVIOUS POSTS November 2017

October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

Integrating our Patient Advocates

Aug 23, 2013 - SWOG's ultimate goal is improving the lives of cancer patients. To do this most effectively, we need to listen to our patients at all stages of research design and execution. To that end, we have taken several steps to more fully and effectively integrate patient advocates into the Group's work, making certain that scientific questions and trial protocols take into account their interests, needs, and concerns.

First, I have appointed a patient advocate representative to my Executive Advisory Committee -- my cabinet -- which meets weekly via web conference call. In a parallel effort with our review process, we are finalizing a template for bringing structured input from the appropriate disease committee patient advocate into every clinical trial concept presented for review on our weekly "triage" call.

Next, we are fortifying our process for recruiting patient advocates. We have openings right now in several of our committees and are working with the National Cancer Institute's Office of Advocacy Relations, and consulting some leading advocacy organizations, to identify the best candidates for those positions. The best candidates are those who know a great deal about their disease process beyond simply their own experience, who understand the standard of care treatments in their disease area, and who have deep roots in advocacy and survivor groups and can act as liaison between SWOG and those communities. I am proud to say those helping SWOG achieve its mission truly meet those criteria.

Our patient advocates are vital partners in selecting, designing, and conducting trials that will be clinically relevant and important to those with cancer and their friends and loved ones. I look forward to further enhancing their involvement with SWOG.

P.S.: We're working to upgrade our web resources. Please take the brief website survey and have your say.


SWOG Logo Disclaimer | Copyright ©1999-2017 SWOG. All rights reserved.
Design and Hosting by nuMedia
SWOG is FISMA CertifiedSWOG is FISMA Certified